4//SEC Filing
CRANDELL KEITH 4
Accession 0000950170-24-041842
CIK 0001782303other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:30 PM ET
Size
34.0 KB
Accession
0000950170-24-041842
Insider Transaction Report
Form 4
NELSEN ROBERT
10% Owner
Transactions
- Conversion
Series A Convertible Preferred Stock
2024-04-02−454,212→ 0 total(indirect: See footnotes)→ Common Stock (454,212 underlying) - Conversion
Series B Convertible Preferred Stock
2024-04-02−227,920→ 0 total(indirect: See footnotes)→ Common Stock (227,920 underlying) - Conversion
Series C Convertible Preferred Stock
2024-04-02−201,465→ 0 total(indirect: See footnotes)→ Common Stock (201,465 underlying) - Conversion
Series C Convertible Preferred Stock
2024-04-02−366,301→ 0 total(indirect: See footnotes)→ Common Stock (366,301 underlying) - Conversion
Common Stock
2024-04-02+589,743→ 617,092 total(indirect: See footnotes) - Conversion
Common Stock
2024-04-02+787,545→ 828,570 total(indirect: See footnotes) - Conversion
Common Stock
2024-04-02+1,048,433→ 1,048,433 total(indirect: See footnotes) - Purchase
Common Stock
2024-04-02$16.00/sh+66,667$1,066,672→ 683,759 total(indirect: See footnotes) - Purchase
Common Stock
2024-04-02$16.00/sh+133,333$2,133,328→ 1,181,766 total(indirect: See footnotes) - Conversion
Series A Convertible Preferred Stock
2024-04-02−424,908→ 0 total(indirect: See footnotes)→ Common Stock (424,908 underlying) - Conversion
Series A Convertible Preferred Stock
2024-04-02−586,080→ 0 total(indirect: See footnotes)→ Common Stock (586,080 underlying) - Conversion
Series C Convertible Preferred Stock
2024-04-02−164,835→ 0 total(indirect: See footnotes)→ Common Stock (164,835 underlying)
GILLIS STEVEN
10% Owner
Transactions
- Conversion
Common Stock
2024-04-02+589,743→ 617,092 total(indirect: See footnotes) - Conversion
Common Stock
2024-04-02+787,545→ 828,570 total(indirect: See footnotes) - Conversion
Common Stock
2024-04-02+1,048,433→ 1,048,433 total(indirect: See footnotes) - Purchase
Common Stock
2024-04-02$16.00/sh+66,667$1,066,672→ 683,759 total(indirect: See footnotes) - Conversion
Series A Convertible Preferred Stock
2024-04-02−424,908→ 0 total(indirect: See footnotes)→ Common Stock (424,908 underlying) - Conversion
Series A Convertible Preferred Stock
2024-04-02−586,080→ 0 total(indirect: See footnotes)→ Common Stock (586,080 underlying) - Conversion
Series A Convertible Preferred Stock
2024-04-02−454,212→ 0 total(indirect: See footnotes)→ Common Stock (454,212 underlying) - Conversion
Series B Convertible Preferred Stock
2024-04-02−227,920→ 0 total(indirect: See footnotes)→ Common Stock (227,920 underlying) - Purchase
Common Stock
2024-04-02$16.00/sh+133,333$2,133,328→ 1,181,766 total(indirect: See footnotes) - Conversion
Series C Convertible Preferred Stock
2024-04-02−164,835→ 0 total(indirect: See footnotes)→ Common Stock (164,835 underlying) - Conversion
Series C Convertible Preferred Stock
2024-04-02−201,465→ 0 total(indirect: See footnotes)→ Common Stock (201,465 underlying) - Conversion
Series C Convertible Preferred Stock
2024-04-02−366,301→ 0 total(indirect: See footnotes)→ Common Stock (366,301 underlying)
CRANDELL KEITH
10% Owner
Transactions
- Conversion
Common Stock
2024-04-02+787,545→ 828,570 total(indirect: See footnotes) - Conversion
Common Stock
2024-04-02+1,048,433→ 1,048,433 total(indirect: See footnotes) - Purchase
Common Stock
2024-04-02$16.00/sh+66,667$1,066,672→ 683,759 total(indirect: See footnotes) - Purchase
Common Stock
2024-04-02$16.00/sh+133,333$2,133,328→ 1,181,766 total(indirect: See footnotes) - Conversion
Series A Convertible Preferred Stock
2024-04-02−424,908→ 0 total(indirect: See footnotes)→ Common Stock (424,908 underlying) - Conversion
Series A Convertible Preferred Stock
2024-04-02−586,080→ 0 total(indirect: See footnotes)→ Common Stock (586,080 underlying) - Conversion
Common Stock
2024-04-02+589,743→ 617,092 total(indirect: See footnotes) - Conversion
Series C Convertible Preferred Stock
2024-04-02−201,465→ 0 total(indirect: See footnotes)→ Common Stock (201,465 underlying) - Conversion
Series C Convertible Preferred Stock
2024-04-02−366,301→ 0 total(indirect: See footnotes)→ Common Stock (366,301 underlying) - Conversion
Series A Convertible Preferred Stock
2024-04-02−454,212→ 0 total(indirect: See footnotes)→ Common Stock (454,212 underlying) - Conversion
Series B Convertible Preferred Stock
2024-04-02−227,920→ 0 total(indirect: See footnotes)→ Common Stock (227,920 underlying) - Conversion
Series C Convertible Preferred Stock
2024-04-02−164,835→ 0 total(indirect: See footnotes)→ Common Stock (164,835 underlying)
BYBEE CLINTON
10% Owner
Transactions
- Conversion
Common Stock
2024-04-02+589,743→ 617,092 total(indirect: See footnotes) - Conversion
Common Stock
2024-04-02+787,545→ 828,570 total(indirect: See footnotes) - Conversion
Common Stock
2024-04-02+1,048,433→ 1,048,433 total(indirect: See footnotes) - Purchase
Common Stock
2024-04-02$16.00/sh+66,667$1,066,672→ 683,759 total(indirect: See footnotes) - Purchase
Common Stock
2024-04-02$16.00/sh+133,333$2,133,328→ 1,181,766 total(indirect: See footnotes) - Conversion
Series A Convertible Preferred Stock
2024-04-02−424,908→ 0 total(indirect: See footnotes)→ Common Stock (424,908 underlying) - Conversion
Series A Convertible Preferred Stock
2024-04-02−586,080→ 0 total(indirect: See footnotes)→ Common Stock (586,080 underlying) - Conversion
Series A Convertible Preferred Stock
2024-04-02−454,212→ 0 total(indirect: See footnotes)→ Common Stock (454,212 underlying) - Conversion
Series B Convertible Preferred Stock
2024-04-02−227,920→ 0 total(indirect: See footnotes)→ Common Stock (227,920 underlying) - Conversion
Series C Convertible Preferred Stock
2024-04-02−366,301→ 0 total(indirect: See footnotes)→ Common Stock (366,301 underlying) - Conversion
Series C Convertible Preferred Stock
2024-04-02−164,835→ 0 total(indirect: See footnotes)→ Common Stock (164,835 underlying) - Conversion
Series C Convertible Preferred Stock
2024-04-02−201,465→ 0 total(indirect: See footnotes)→ Common Stock (201,465 underlying)
Footnotes (8)
- [F1]Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.
- [F2]Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX). ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX.
- [F3]Represents shares held directly by ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage). ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH IX Overage.
- [F4]ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any.
- [F5]Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage). ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage.
- [F6]ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any.
- [F7]Reflects shares purchased by ARCH IX in the Issuer's initial public offering.
- [F8]Reflects shares purchased by ARCH X Overage in the Issuer's initial public offering.
Documents
Issuer
Boundless Bio, Inc.
CIK 0001782303
Entity typeother
Related Parties
1- filerCIK 0001219039
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:30 PM ET
- Size
- 34.0 KB